List of Tables
Table 1. Chronic Heart Failure Treatment Market Trends
Table 2. Chronic Heart Failure Treatment Market Drivers & Opportunity
Table 3. Chronic Heart Failure Treatment Market Challenges
Table 4. Chronic Heart Failure Treatment Market Restraints
Table 5. Global Chronic Heart Failure Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Chronic Heart Failure Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Chronic Heart Failure Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Chronic Heart Failure Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Chronic Heart Failure Treatment
Table 10. Global Chronic Heart Failure Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Chronic Heart Failure Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Chronic Heart Failure Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Chronic Heart Failure Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Chronic Heart Failure Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Chronic Heart Failure Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Chronic Heart Failure Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Chronic Heart Failure Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Chronic Heart Failure Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Chronic Heart Failure Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Chronic Heart Failure Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Chronic Heart Failure Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Chronic Heart Failure Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Chronic Heart Failure Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Chronic Heart Failure Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Chronic Heart Failure Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Chronic Heart Failure Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Chronic Heart Failure Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Chronic Heart Failure Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Medtronic Basic Information List
Table 32. Medtronic Description and Business Overview
Table 33. Medtronic Chronic Heart Failure Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Medtronic (2019-2024)
Table 35. Medtronic Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Chronic Heart Failure Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Johnson & Johnson Basic Information List
Table 42. Johnson & Johnson Description and Business Overview
Table 43. Johnson & Johnson Chronic Heart Failure Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Johnson & Johnson (2019-2024)
Table 45. Johnson & Johnson Recent Developments
Table 46. Merck Basic Information List
Table 47. Merck Description and Business Overview
Table 48. Merck Chronic Heart Failure Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Merck (2019-2024)
Table 50. Merck Recent Developments
Table 51. Stanley Pharmaceuticals Basic Information List
Table 52. Stanley Pharmaceuticals Description and Business Overview
Table 53. Stanley Pharmaceuticals Chronic Heart Failure Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Stanley Pharmaceuticals (2019-2024)
Table 55. Stanley Pharmaceuticals Recent Developments
Table 56. New Haven Pharmaceuticals, Inc. Basic Information List
Table 57. New Haven Pharmaceuticals, Inc. Description and Business Overview
Table 58. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of New Haven Pharmaceuticals, Inc. (2019-2024)
Table 60. New Haven Pharmaceuticals, Inc. Recent Developments
Table 61. Boston Scientific Corporation Basic Information List
Table 62. Boston Scientific Corporation Description and Business Overview
Table 63. Boston Scientific Corporation Chronic Heart Failure Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Boston Scientific Corporation (2019-2024)
Table 65. Boston Scientific Corporation Recent Developments
Table 66. HeartWare Basic Information List
Table 67. HeartWare Description and Business Overview
Table 68. HeartWare Chronic Heart Failure Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of HeartWare (2019-2024)
Table 70. HeartWare Recent Developments
Table 71. Pfizer Basic Information List
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Chronic Heart Failure Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Pfizer (2019-2024)
Table 75. Pfizer Recent Developments
Table 76. GlaxoSmithKline plc Basic Information List
Table 77. GlaxoSmithKline plc Description and Business Overview
Table 78. GlaxoSmithKline plc Chronic Heart Failure Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of GlaxoSmithKline plc (2019-2024)
Table 80. GlaxoSmithKline plc Recent Developments
Table 81. Novartis International AG Basic Information List
Table 82. Novartis International AG Description and Business Overview
Table 83. Novartis International AG Chronic Heart Failure Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Novartis International AG (2019-2024)
Table 85. Novartis International AG Recent Developments
Table 86. Biovail Corporation Basic Information List
Table 87. Biovail Corporation Description and Business Overview
Table 88. Biovail Corporation Chronic Heart Failure Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Biovail Corporation (2019-2024)
Table 90. Biovail Corporation Recent Developments
Table 91. Bristol-Myers Squibb Company Basic Information List
Table 92. Bristol-Myers Squibb Company Description and Business Overview
Table 93. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Bristol-Myers Squibb Company (2019-2024)
Table 95. Bristol-Myers Squibb Company Recent Developments
Table 96. Abiomed Basic Information List
Table 97. Abiomed Description and Business Overview
Table 98. Abiomed Chronic Heart Failure Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Abiomed (2019-2024)
Table 100. Abiomed Recent Developments
Table 101. Symplmed Pharmaceuticals Basic Information List
Table 102. Symplmed Pharmaceuticals Description and Business Overview
Table 103. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Products, Services and Solutions
Table 104. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Symplmed Pharmaceuticals (2019-2024)
Table 105. Symplmed Pharmaceuticals Recent Developments
Table 106. Berlin Heart GmbH Basic Information List
Table 107. Berlin Heart GmbH Description and Business Overview
Table 108. Berlin Heart GmbH Chronic Heart Failure Treatment Products, Services and Solutions
Table 109. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Berlin Heart GmbH (2019-2024)
Table 110. Berlin Heart GmbH Recent Developments
Table 111. ReliantHeart, Inc. Basic Information List
Table 112. ReliantHeart, Inc. Description and Business Overview
Table 113. ReliantHeart, Inc. Chronic Heart Failure Treatment Products, Services and Solutions
Table 114. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of ReliantHeart, Inc. (2019-2024)
Table 115. ReliantHeart, Inc. Recent Developments
Table 116. Cardiokinetix Basic Information List
Table 117. Cardiokinetix Description and Business Overview
Table 118. Cardiokinetix Chronic Heart Failure Treatment Products, Services and Solutions
Table 119. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Cardiokinetix (2019-2024)
Table 120. Cardiokinetix Recent Developments
Table 121. Biotronik Basic Information List
Table 122. Biotronik Description and Business Overview
Table 123. Biotronik Chronic Heart Failure Treatment Products, Services and Solutions
Table 124. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Biotronik (2019-2024)
Table 125. Biotronik Recent Developments
Table 126. Jarvik Heart Basic Information List
Table 127. Jarvik Heart Description and Business Overview
Table 128. Jarvik Heart Chronic Heart Failure Treatment Products, Services and Solutions
Table 129. Revenue (US$ Million) in Chronic Heart Failure Treatment Business of Jarvik Heart (2019-2024)
Table 130. Jarvik Heart Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Chronic Heart Failure Treatment Downstream Customers
Table 134. Chronic Heart Failure Treatment Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Chronic Heart Failure Treatment Product Picture
Figure 2. Global Chronic Heart Failure Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Chronic Heart Failure Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Chronic Heart Failure Treatment Report Years Considered
Figure 5. Global Chronic Heart Failure Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Heart Failure Treatment Revenue in 2023
Figure 7. Chronic Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. ICDs Picture
Figure 9. VADs Picture
Figure 10. Drugs Picture
Figure 11. Others Picture
Figure 12. Global Chronic Heart Failure Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Chronic Heart Failure Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital
Figure 15. Product Picture of Clinic
Figure 16. Product Picture of Household
Figure 17. Product Picture of Others
Figure 18. Global Chronic Heart Failure Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Chronic Heart Failure Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Chronic Heart Failure Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Chronic Heart Failure Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Chronic Heart Failure Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Chronic Heart Failure Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Chronic Heart Failure Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Chronic Heart Failure Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Chronic Heart Failure Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Chronic Heart Failure Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Chronic Heart Failure Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Chronic Heart Failure Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Chronic Heart Failure Treatment Sales Value (%), (2019-2030)
Figure 31. United States Chronic Heart Failure Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Chronic Heart Failure Treatment Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Chronic Heart Failure Treatment Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Chronic Heart Failure Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Chronic Heart Failure Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Chronic Heart Failure Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. China Chronic Heart Failure Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Chronic Heart Failure Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. China Chronic Heart Failure Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Chronic Heart Failure Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Chronic Heart Failure Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Chronic Heart Failure Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Chronic Heart Failure Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Chronic Heart Failure Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Chronic Heart Failure Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Chronic Heart Failure Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Chronic Heart Failure Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Chronic Heart Failure Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. India Chronic Heart Failure Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Chronic Heart Failure Treatment Sales Value by Type (%), 2023 VS 2030
Figure 51. India Chronic Heart Failure Treatment Sales Value by Application (%), 2023 VS 2030
Figure 52. Chronic Heart Failure Treatment Industrial Chain
Figure 53. Chronic Heart Failure Treatment Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
